BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 12829253)

  • 1. LKB1, a protein kinase regulating cell proliferation and polarity.
    Boudeau J; Sapkota G; Alessi DR
    FEBS Lett; 2003 Jul; 546(1):159-65. PubMed ID: 12829253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LKB1, a novel serine/threonine protein kinase and potential tumour suppressor, is phosphorylated by cAMP-dependent protein kinase (PKA) and prenylated in vivo.
    Collins SP; Reoma JL; Gamm DM; Uhler MD
    Biochem J; 2000 Feb; 345 Pt 3(Pt 3):673-80. PubMed ID: 10642527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and characterization of four novel phosphorylation sites (Ser31, Ser325, Thr336 and Thr366) on LKB1/STK11, the protein kinase mutated in Peutz-Jeghers cancer syndrome.
    Sapkota GP; Boudeau J; Deak M; Kieloch A; Morrice N; Alessi DR
    Biochem J; 2002 Mar; 362(Pt 2):481-90. PubMed ID: 11853558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A role for Drosophila LKB1 in anterior-posterior axis formation and epithelial polarity.
    Martin SG; St Johnston D
    Nature; 2003 Jan; 421(6921):379-84. PubMed ID: 12540903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorylation of the protein kinase mutated in Peutz-Jeghers cancer syndrome, LKB1/STK11, at Ser431 by p90(RSK) and cAMP-dependent protein kinase, but not its farnesylation at Cys(433), is essential for LKB1 to suppress cell vrowth.
    Sapkota GP; Kieloch A; Lizcano JM; Lain S; Arthur JS; Williams MR; Morrice N; Deak M; Alessi DR
    J Biol Chem; 2001 Jun; 276(22):19469-82. PubMed ID: 11297520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional analysis of Peutz-Jeghers mutations reveals that the LKB1 C-terminal region exerts a crucial role in regulating both the AMPK pathway and the cell polarity.
    Forcet C; Etienne-Manneville S; Gaude H; Fournier L; Debilly S; Salmi M; Baas A; Olschwang S; Clevers H; Billaud M
    Hum Mol Genet; 2005 May; 14(10):1283-92. PubMed ID: 15800014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A serine/threonine kinase gene defective in Peutz-Jeghers syndrome.
    Hemminki A; Markie D; Tomlinson I; Avizienyte E; Roth S; Loukola A; Bignell G; Warren W; Aminoff M; Höglund P; Järvinen H; Kristo P; Pelin K; Ridanpää M; Salovaara R; Toro T; Bodmer W; Olschwang S; Olsen AS; Stratton MR; de la Chapelle A; Aaltonen LA
    Nature; 1998 Jan; 391(6663):184-7. PubMed ID: 9428765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the LKB1-STRAD-MO25 complex.
    Boudeau J; Scott JW; Resta N; Deak M; Kieloch A; Komander D; Hardie DG; Prescott AR; van Aalten DM; Alessi DR
    J Cell Sci; 2004 Dec; 117(Pt 26):6365-75. PubMed ID: 15561763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LKB1-dependent signaling pathways.
    Alessi DR; Sakamoto K; Bayascas JR
    Annu Rev Biochem; 2006; 75():137-63. PubMed ID: 16756488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The mouse Peutz-Jeghers syndrome gene Lkb1 encodes a nuclear protein kinase.
    Smith DP; Spicer J; Smith A; Swift S; Ashworth A
    Hum Mol Genet; 1999 Aug; 8(8):1479-85. PubMed ID: 10400995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of the TSC pathway by LKB1: evidence of a molecular link between tuberous sclerosis complex and Peutz-Jeghers syndrome.
    Corradetti MN; Inoki K; Bardeesy N; DePinho RA; Guan KL
    Genes Dev; 2004 Jul; 18(13):1533-8. PubMed ID: 15231735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent progress on liver kinase B1 (LKB1): expression, regulation, downstream signaling and cancer suppressive function.
    Gan RY; Li HB
    Int J Mol Sci; 2014 Sep; 15(9):16698-718. PubMed ID: 25244018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The molecular mechanisms that underlie the tumor suppressor function of LKB1.
    Fan D; Ma C; Zhang H
    Acta Biochim Biophys Sin (Shanghai); 2009 Feb; 41(2):97-107. PubMed ID: 19204826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of cytoplasmic retention ability of mutant LKB1 found in Peutz-Jeghers syndrome patients.
    Nezu J; Oku A; Shimane M
    Biochem Biophys Res Commun; 1999 Aug; 261(3):750-5. PubMed ID: 10441497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of the Wnt signalling component PAR1A by the Peutz-Jeghers syndrome kinase LKB1.
    Spicer J; Rayter S; Young N; Elliott R; Ashworth A; Smith D
    Oncogene; 2003 Jul; 22(30):4752-6. PubMed ID: 12879020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional analysis of LKB1/STK11 mutants and two aberrant isoforms found in Peutz-Jeghers Syndrome patients.
    Boudeau J; Kieloch A; Alessi DR; Stella A; Guanti G; Resta N
    Hum Mutat; 2003 Feb; 21(2):172. PubMed ID: 12552571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LKB1 interacts with and phosphorylates PTEN: a functional link between two proteins involved in cancer predisposing syndromes.
    Mehenni H; Lin-Marq N; Buchet-Poyau K; Reymond A; Collart MA; Picard D; Antonarakis SE
    Hum Mol Genet; 2005 Aug; 14(15):2209-19. PubMed ID: 15987703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stability of the Peutz-Jeghers syndrome kinase LKB1 requires its binding to the molecular chaperones Hsp90/Cdc37.
    Nony P; Gaude H; Rossel M; Fournier L; Rouault JP; Billaud M
    Oncogene; 2003 Dec; 22(57):9165-75. PubMed ID: 14668798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The LKB1 tumor suppressor kinase in human disease.
    Katajisto P; Vallenius T; Vaahtomeri K; Ekman N; Udd L; Tiainen M; Mäkelä TP
    Biochim Biophys Acta; 2007 Jan; 1775(1):63-75. PubMed ID: 17010524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Posttranslational regulation of liver kinase B1 in human cancer.
    Hu L; Liu M; Tang B; Li Q; Pan BS; Xu C; Lin HK
    J Biol Chem; 2023 Apr; 299(4):104570. PubMed ID: 36870679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.